{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:58:20Z","timestamp":1770962300802,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.ejogrb.2005.08.006","type":"journal-article","created":{"date-parts":[[2005,9,27]],"date-time":"2005-09-27T10:19:28Z","timestamp":1127816368000},"page":"120-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Duloxetine for the treatment of stress urinary incontinence in women: An integrated analysis of safety"],"prefix":"10.1016","volume":"125","author":[{"given":"Daniel J.","family":"Hurley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine L.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilker","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Viktrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simin K.","family":"Baygani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2005.08.006_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of the International Continence Society","volume":"2121","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mob.2002.124840","article-title":"Duloxetine versus placebo in the treatment of stress urinary incontinence","volume":"187","author":"Norton","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib3","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/01.ju.0000080708.87092.cc","article-title":"Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence","volume":"170","author":"Dmochowski","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1471-0528.2004.00067.x","article-title":"Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence","volume":"111","author":"van Kerrebroeck","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1464-410X.2004.04607.x","article-title":"Duloxetine vs. placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial","volume":"93","author":"Millard","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","article-title":"Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors","volume":"25","author":"Bymaster","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1185\/030079903125002126","article-title":"Pharmacological agents used for the treatment of stress urinary incontinence in women","volume":"19","author":"Viktrup","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0022-3565(25)10548-X","article-title":"Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat","volume":"274","author":"Thor","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-0348-8183-8_5","article-title":"Dual serotonin and noradrenaline uptake inhibitor class of anti-depressants-potential for greater efficacy or just hype?","volume":"58","author":"Wong","year":"2002","journal-title":"Prog Drug Res"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib10","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1016\/j.bmcl.2004.04.066","article-title":"Synthesis and biological activity of some known and putative duloxetine metabolites","volume":"14","author":"Kuo","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib11","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1097\/01.ju.0000124909.31527.a9","article-title":"Validation of a clinical algorithm indicative of urodynamic stress incontinence for use in large-scale clinical trials","volume":"171","author":"Yalcin","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-199920030-00007","article-title":"Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system","volume":"20","author":"Spigset","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000071826","article-title":"Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea","volume":"48","author":"Ueda","year":"2003","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000227054","article-title":"Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists","volume":"49","author":"Tyers","year":"1992","journal-title":"Oncology"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00001574-199403000-00012","article-title":"New Developments in the Enteric Nervous System","volume":"10","author":"Gershon","year":"1994","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2165\/00023210-199708050-00005","article-title":"Nausea and vomiting associated with selective serotonin reuptake inhibitors. Incidence, mechanisms and management","volume":"November 8","author":"McManis","year":"1997","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib17","first-page":"106","article-title":"Duloxetine for the treatment of major depressive disorder","volume":"36","author":"Nemeroff","year":"2002","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/01.AOG.0000134525.86480.0f","article-title":"Pharmacological treatment of women awaiting surgery for stress urinary incontinence","volume":"104","author":"Cardozo","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib19","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/(SICI)1099-1077(199802)13:1+<S3::AID-HUP981>3.0.CO;2-O","article-title":"The human pharmacology of reboxetine","volume":"13","author":"Szabadi","year":"1998","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib20","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00004850-199905001-00005","article-title":"Predicting response: noradrenaline reuptake inhibition","volume":"14","author":"Montgomery","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib21","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","article-title":"Phenylpropanolamine and the risk of hemorrhagic stroke","volume":"343","author":"Kernan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2005.08.006_bib22","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1056\/NEJM200012213432510","article-title":"The FDA, regulation, and the risk of stroke","volume":"343","author":"Fleming","year":"2000","journal-title":"N Engl J Med"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211505004288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211505004288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:15:24Z","timestamp":1759554924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211505004288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0301211505004288"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.08.006","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Duloxetine for the treatment of stress urinary incontinence in women: An integrated analysis of safety","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}